BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 37478845)

  • 1. A lncRNA from the FTO locus acts as a suppressor of the m
    Zhang J; Wei J; Sun R; Sheng H; Yin K; Pan Y; Jimenez R; Chen S; Cui XL; Zou Z; Yue Z; Emch MJ; Hawse JR; Wang L; He HH; Xia S; Han B; He C; Huang H
    Mol Cell; 2023 Aug; 83(15):2692-2708.e7. PubMed ID: 37478845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2.
    Wang F; Hu Y; Wang H; Hu P; Xiong H; Zeng Z; Han S; Wang D; Wang J; Zhao Y; Huang Y; Zhuo W; Lv G; Zhao G
    J Exp Clin Cancer Res; 2023 Oct; 42(1):267. PubMed ID: 37840133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusaric acid decreases p53 expression by altering promoter methylation and m6A RNA methylation in human hepatocellular carcinoma (HepG2) cells.
    Ghazi T; Nagiah S; Chuturgoon AA
    Epigenetics; 2021 Jan; 16(1):79-91. PubMed ID: 32631113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. m
    Takemoto S; Nakano M; Fukami T; Nakajima M
    Biochem Pharmacol; 2021 Nov; 193():114766. PubMed ID: 34536357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meclofenamic acid promotes cisplatin-induced acute kidney injury by inhibiting fat mass and obesity-associated protein-mediated m
    Zhou P; Wu M; Ye C; Xu Q; Wang L
    J Biol Chem; 2019 Nov; 294(45):16908-16917. PubMed ID: 31578283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FTO-Dependent
    Huang H; Wang Y; Kandpal M; Zhao G; Cardenas H; Ji Y; Chaparala A; Tanner EJ; Chen J; Davuluri RV; Matei D
    Cancer Res; 2020 Aug; 80(16):3200-3214. PubMed ID: 32606006
    [No Abstract]   [Full Text] [Related]  

  • 7. Ibuprofen promotes p75 neurotrophin receptor expression through modifying promoter methylation and N6-methyladenosine-RNA-methylation in human gastric cancer cells.
    Jin H; Wu Z; Tan B; Liu Z; Zu Z; Wu X; Bi Y; Hu X
    Bioengineered; 2022 Jun; 13(6):14595-14604. PubMed ID: 35758042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. m
    Cui Q; Shi H; Ye P; Li L; Qu Q; Sun G; Sun G; Lu Z; Huang Y; Yang CG; Riggs AD; He C; Shi Y
    Cell Rep; 2017 Mar; 18(11):2622-2634. PubMed ID: 28297667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. m
    Hou J; Shan H; Zhang Y; Fan Y; Wu B
    Am J Otolaryngol; 2020; 41(4):102547. PubMed ID: 32474328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
    Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H
    J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay between RNA Methylation Eraser FTO and Writer METTL3 in Renal Clear Cell Carcinoma Patient Survival.
    Zhao J; Lu L
    Recent Pat Anticancer Drug Discov; 2021; 16(3):363-376. PubMed ID: 33563180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose Is Involved in the Dynamic Regulation of m6A in Patients With Type 2 Diabetes.
    Yang Y; Shen F; Huang W; Qin S; Huang JT; Sergi C; Yuan BF; Liu SM
    J Clin Endocrinol Metab; 2019 Mar; 104(3):665-673. PubMed ID: 30137347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. m
    Liu J; Ren D; Du Z; Wang H; Zhang H; Jin Y
    Biochem Biophys Res Commun; 2018 Aug; 502(4):456-464. PubMed ID: 29842885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on the Correlation Between Regulatory Proteins of N
    Sun Y; Liu G; Li M; Wang L; He Z; Gu S
    Biol Trace Elem Res; 2023 May; 201(5):2294-2302. PubMed ID: 35794303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel evidence for m
    Shimura T; Kandimalla R; Okugawa Y; Ohi M; Toiyama Y; He C; Goel A
    Br J Cancer; 2022 Feb; 126(2):228-237. PubMed ID: 34675398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dynamics of FTO binding and demethylation from the m
    Li Y; Wu K; Quan W; Yu L; Chen S; Cheng C; Wu Q; Zhao S; Zhang Y; Zhou L
    RNA Biol; 2019 Sep; 16(9):1179-1189. PubMed ID: 31149892
    [No Abstract]   [Full Text] [Related]  

  • 17. The antagonistic effect of FTO on METTL14 promotes AKT3 m
    Wei R; Zhao F; Kong L; Pu Y; Li Y; Zang C
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):131. PubMed ID: 38491196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of Human Nuclear RNA m⁶A Methyltransferases and Demethylases and Biochemical Characterization of Their Catalytic Activity.
    Liu J; Yue Y; He C
    Methods Enzymol; 2015; 560():117-30. PubMed ID: 26253968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct roles of Fto and Mettl3 in controlling development of the cerebral cortex through transcriptional and translational regulations.
    Du K; Zhang Z; Zeng Z; Tang J; Lee T; Sun T
    Cell Death Dis; 2021 Jul; 12(7):700. PubMed ID: 34262022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical Inhibitors Targeting the Oncogenic m
    Huang Y; Xia W; Dong Z; Yang CG
    Acc Chem Res; 2023 Nov; 56(21):3010-3022. PubMed ID: 37889223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.